Articles tagged: Medical Research

NIH, FDA, drug approval

115 articles

Makary Set to Lead America's Most Powerful Drug Regulator

U.S. President-elect Donald Trump is expected to nominate Johns Hopkins surgeon Martin Makary to head the FDA. Makary, known for his views on natural immunity and opposition to COVID vaccine mandates, could bring unconventional changes to the influential agency responsible for overseeing drugs, food safety, and medical devices.

Devdiscourse by Devdiscourse

Jay Bhattacharya: Leading Candidate for NIH Director Role

Jay Bhattacharya is reportedly President-elect Donald Trump's top choice for NIH director. Bhattacharya impressed Trump's cabinet pick for HHS with his innovative ideas for NIH overhaul, focusing on funding research. His selection aligns with Trump's earlier choice of Robert F. Kennedy Jr. to lead HHS.

Devdiscourse by Devdiscourse

Kennedy’s lawyer has asked the FDA to revoke its approval of the polio vaccine

President-elect Donald Trump has praised the polio vaccine as the “greatest thing,” but a lawyer affiliated with Trump’s pick to lead the country’s top health agency has petitioned the US Food and Drug Administration to revoke approval of the vaccine used in the United States.

Cable News Network by Cable News Network

FDA Rehiring Furloughed Scientists Amid Neuralink Trial Controversy

The FDA is seeking to rehire some of the scientists recently fired amid pressure from Elon Musk, who has ties to Neuralink. The agency aims to bring back around 300 personnel after Trump's abrupt dismissals. The rehirings follow ongoing Neuralink trials, which the agency approved despite past safety concerns.

Devdiscourse by Devdiscourse

Health News Brief: Budget Cuts, Rising Measles, and Medical Advancements

The Trump administration proposes significant budget cuts affecting health and research sectors. Texas reports 683 measles cases amid nationwide outbreaks. Medical device demand boosts Stryker's earnings. The FDA reviews weight-loss drugs, while Neuralink's device for speech restoration gains breakthrough status. Thailand faces its first anthrax death in decades.

Devdiscourse by Devdiscourse

Revolutionary COVID-19 Vaccine: Moderna's mNexspike Approved

The US FDA approved Moderna's next-generation COVID-19 vaccine, mNexspike, for adults 65+ and at-risk individuals aged 12-64. This low-dose option enhances immunity with fewer restrictions compared to previous vaccines. The decision followed a study affirming its safety and effectiveness, despite financial hurdles from the Trump administration.

Devdiscourse by Devdiscourse

The one thing the Trump administration got very right

If there’s anything the Trump administration has gotten unequivocally right (besides inadvertently helping Mark Carney become prime minister of Canada), it’s this: Modern science, for all its remarkable capabilities, still remains far too dependent on one of …

Vox by Marina Bolotnikova

RFK’s attack on children’s vaccines, explained

This story appeared in The Logoff, a daily newsletter that helps you stay informed about the Trump administration without letting political news take over your life. Subscribe here. Welcome to The Logoff: An influential panel that makes vaccine recommendation…

Vox by Patrick Reis

Creating Bird Flu Vaccines for Humans at a Biosecure Laboratory

This San Antonio, Tex., lab takes biosecurity seriously. Suit up with its scientists and go behind the scenes of the science of vaccine creation.

Scientific American by Naeem Amarsy, Jeffery DelViscio, Fonda Mwangi, Alex Sugiura, Rachel Feltman

Smoking Cessation Aid Cytisinicline Could Soon Get FDA Approval

Besides nicotine replacement therapies, the FDA has only approved two smoking cessation drugs without nicotine. This may change soon if cytisinicline gets approved.

Forbes by Joshua P. Cohen, Senior Contributor, Joshua P. Cohen, Senior Contributor https://www.forbes.com/sites/joshuacohen/

Novel Access Model For Sickle Cell Disease Gene Therapy Could Be Template

If successful, the access model for sickle cell disease gene therapies could serve as a blueprint for other such treatments that have faced major patient access barriers.

Forbes by Joshua P. Cohen, Senior Contributor, Joshua P. Cohen, Senior Contributor https://www.forbes.com/sites/joshuacohen/

HHS responds to report about autism and acetaminophen

A report that health secretary Robert F. Kennedy, Jr. has promised will come out this month will look at the causes of autism. Many worry it will have claims unsupported by science.

NPR by Yuki Noguchi

Letters from Our Readers

Readers respond to Rachel Aviv’s report on a schizophrenia patient who turned out to have an autoimmune disease, Zach Helfand’s Talk of the Town story about Youman Wilder, and Hua Hsu’s article on A.I. and education.

The New Yorker by The New Yorker

RFK Jr.’s New Tylenol-Autism Whisperer

William Parker, who says that children taking Tylenol causes autism, has spoken with the health secretary five times in the past month.

The Atlantic by Tom Bartlett

Autism Has No Single Cause, Research Shows

Scientists will not find a simple answer to how autism arises, despite Robert F. Kennedy, Jr.’s promise to announce its causes sometime this month. Here’s what makes the condition so staggeringly complex

Scientific American by Allison Parshall

Magic Mushroom Edibles Found to Contain No Psilocybin

Researchers tested 12 “magic mushroom” edibles. None contained psilocybin, but most contained undisclosed ingredients, including synthetic drugs whose safety hasn’t been tested in humans

Scientific American by Allison Parshall

I Want A New Drug. A Vaccine Even. And A Functioning FDA, CDC, NIH, Etc…

My cancer is back. This is disappointing but not unexpected; of the 2/3 of people who survive their first bout with ovarian cancer, 80% usually have it recur at some point. For me it was sooner than expected, and disheartening because, even if I beat it back …

Techdirt by Cathy Gellis

RFK Jr. Is Doubling Down On Multiple Unproven Links To Autism

Kennedy’s doubling down on disputed links isn't a one-off. He has often done this regarding exposure to substances like acetaminophen that he thinks are linked to autism.

Forbes by Joshua P. Cohen, Senior Contributor, Joshua P. Cohen, Senior Contributor https://www.forbes.com/sites/joshuacohen/

The Dangerous Data Gap in Pregnancy Drug Research

Despite the widespread use of medication during pregnancy, a lack of clinical research leaves patients and doctors navigating treatment with dangerously few data.

Scientific American by Rachel Feltman, Tanya Lewis, Fonda Mwangi, Alex Sugiura

How New Trump Multiyear Policy Makes NIH Grants Even Harder To Get

The new Trump administration multiyear funding policy for NIH grants has dropped National Cancer Institute grant funding rates from one in 10 applicants to one in 25.

Forbes by Bruce Y. Lee, Senior Contributor, Bruce Y. Lee, Senior Contributor https://www.forbes.com/sites/brucelee/

Scientists just shattered a major exercise myth

New research from Australia overturns the old idea that exercise “uses up” heartbeats. It shows that fitter people actually use fewer total heartbeats each day thanks to their lower resting heart rates, even when accounting for workouts. Athletes’ hearts beat…

Science Daily

BMY Gains Attention as Bayer Reports FXIa Trial Success

Bristol-Myers Squibb Company (NYSE:BMY) is included among the 15 Best Boring Dividend Stocks to Buy. Bayer repor⁠t​ed positive Phase‌ 3 result⁠s for its FXIa ...

Yahoo Entertainment by Vardah Gill

NIH pivots away from agency-directed science

US biomedical funding behemoth says the approach will boost innovation, but some researchers worry that understudied areas of science will suffer.

Nature.com by Max Kozlov

A synthetic angiotensin II/ACE2-based hormone shunt controlling experimental hypertension

Chronic diseases require lifelong maintenance. Here, the authors present ARCH, a closed-loop genetic circuit that autonomously maintains Angiotensin-II homeostasis, demonstrating translational potential against RAS-dependent hypertension.

Nature.com by Gokberk Unal, Maysam Mansouri, Yu-Qing Xie, Christian Mueller, Ghislaine Charpin-El Hamri, Martin Fussenegger

Robert Langer

The M.I.T. professor and expert on innovation on why science is worth celebrating

Scientific American by Megha Satyanarayana

Is Grandpa Pudding Brains the mystery patient getting the super-Ozempic?

A very connected 79-year-old chonker reportedly got access to Eli Lilly's experimental obesity drug retatrutide, and the White House will not directly say whether that man is McDonald's slurping Grandpa Pudding Brains. Raw Story summarizes STAT's report that …

Boing Boing by Jason Weisberger

WATCH: Humanoid robots perform surgery

For the first time, surgeons at UC San Diego have operated using humanoid robots, removing gallbladders in two procedures on pigs, a key step before any human trials.

Abcnews.com by ABC News